General Methods in Biomarker Research and their Applications

The well-being of humankind is dependent upon advances in biological and clinical sciences. For many diseases, an early diagnosis and objective measures of outcomes are essential for reducing mortality and morbidity. Part of this package entails the appropriate use of biomarkers. These are biologica...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Preedy, Victor R. (Editor, http://id.loc.gov/vocabulary/relators/edt), Patel, Vinood B. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Subjects:
Online Access:https://doi.org/10.1007/978-94-007-7696-8
LEADER 04509nam a22004935i 4500
001 978-94-007-7696-8
003 DE-He213
005 20210617190513.0
007 cr nn 008mamaa
008 150622s2015 ne | s |||| 0|eng d
020 |a 9789400776968  |9 978-94-007-7696-8 
024 7 |a 10.1007/978-94-007-7696-8  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a General Methods in Biomarker Research and their Applications  |h [electronic resource] /  |c edited by Victor R. Preedy, Vinood B. Patel. 
250 |a 1st ed. 2015. 
264 1 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2015. 
300 |a 204 illus., 130 illus. in color. eReference.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Biomarker for Amyotrophic Lateral Sclerosis (Motor Neurone Disease) -- Biomarkers and their applications to toxicology and toxicogenomics -- Biomarkers for Depression -- Biomarkers in Chronic Obstructive Pulmonary Disease (COPD): Current Concerns and Future Prospects -- Biomarkers in Urine and Use of Creatinine -- Biomarkers of Graft-Versus-Host Disease -- Biomarkers of Menopause -- Biomarkers of Parkinson's Disease -- Biomarkers of Vector Bites -- Biomarkers of the menopause.- Chronic Heart Failure and Serum Collagen -- FABP3 as biomarkers -- Fetal Membrane Biomarkers.- Flow Cytometry as Platform for Biomarker Evaluation -- Formalin-fixed paraffin-embedded tissue (FFPET) sections for biomarker discovery -- Glycomics as biomarkers -- Inflammasome Proteins as Biomarkers of Injury and Disease -- Isoprostanes as biomarkers of disease and early biological effect.-Mass spectrometry for biomarker discovery -- Micro RNA as Biomarker for Brain Injury -- MIP-1alpha as biomarker -- Natriuretic Peptides for Diagnosis, Prognosis and Management of Heart Failure -- OMICS-based approaches to biomarker discovery and challenges of subsequent validation -- Pediatric biomarkers after cardac surgery -- Pentraxin 3 as Biomarker -- Pfetin: Novel prognostic biomarker -- Plasma galectin-3 as biomarker -- S100B as a Biomarker -- Salivary amylase as a stress biomarker -- Seasonal allergic rhinitis and systems biology-oriented biomarker discovery -- Serum Heat Shock Proteins as Novel Biomarker for Heart Failure -- Urinary Biomarkers of Environmental Health: Jet Fuel -- YKL-40 as Biomarker: Focus on Cardiovascular Disease. 
520 |a The well-being of humankind is dependent upon advances in biological and clinical sciences. For many diseases, an early diagnosis and objective measures of outcomes are essential for reducing mortality and morbidity. Part of this package entails the appropriate use of biomarkers. These are biological indicators which often are used routinely in the clinical setting. Recent advances in the chemical and physical sciences have enabled new biomarkers to be developed. This does not mean that traditional markers are redundant as detailed investigations have identified both limitations and advantages in their usage as well as new applications.  This book General Methods in Biomarker Research and their Applications combines both traditional, new and emerging biomarkers in a single publication. The chapters contained in this book have wide applicability to many diseases. 
650 0 |a Cancer research. 
650 0 |a Oncology  . 
650 0 |a Pharmacology. 
650 1 4 |a Cancer Research.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B11001 
650 2 4 |a Oncology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33160 
650 2 4 |a Pharmacology/Toxicology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B21007 
700 1 |a Preedy, Victor R.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Patel, Vinood B.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eReference 
776 0 8 |i Printed edition:  |z 9789400776975 
776 0 8 |i Printed edition:  |z 9789400776951 
856 4 0 |u https://doi.org/10.1007/978-94-007-7696-8 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXRB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Reference Module Biomedical and Life Sciences (SpringerNature-43744)